Requests that the FDA Open a Docket, Hold a Part 15 Public Hearing Regarding the Off-Label Use of Estrogen in Natal Males for Gender Affirmation, and Consider Regulatory Action Including a Boxed Warning Under 21 C.F.R. § 201.80(e)
🏛 Food and Drug Administration (FDA)FDA-2025-P-7321
Documents
2
Total comments
10,031
28 awaiting analysis
Comment status
Open
Last activity
Jul 29, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Dec 23, 2025No comment period💬 10,031